Helen M. Thackray
2019 - GlycoMimetics
In 2019, Helen M. Thackray earned a total compensation of $1.3M as Chief Medical Officer at GlycoMimetics, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,776 |
|---|---|
| Option Awards | $696,000 |
| Salary | $437,400 |
| Other | $8,546 |
| Total | $1,300,722 |
Thackray received $696K in option awards, accounting for 54% of the total pay in 2019.
Thackray also received $158.8K in non-equity incentive plan, $437.4K in salary and $8.5K in other compensation.
Rankings
In 2019, Helen M. Thackray's compensation ranked 8,023rd out of 13,971 executives tracked by ExecPay. In other words, Thackray earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,023 out of 13,971 | 43rd |
Division Manufacturing | 3,166 out of 5,701 | 45th |
Major group Chemicals And Allied Products | 1,204 out of 2,200 | 45th |
Industry group Drugs | 1,026 out of 1,886 | 46th |
Industry Pharmaceutical Preparations | 764 out of 1,398 | 45th |
Source: SEC filing on April 16, 2020.
Thackray's colleagues
We found two more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2019.